Medicare Enrolled

Dr. Barjinder Singh, M.D.

Hematology & Oncology · Mount Pleasant, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2101 MULBERRY AVE, Mount Pleasant, TX 75455
9034344850
In practice since 2005 (20 years)
NPI: 1114926847 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Barjinder Singh is a hematology & oncology in Mount Pleasant, TX, with 20 years in practice. Based on federal Medicare data, Dr. Singh performed 274 Medicare services across 165 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $2,767 from 46 pharmaceutical and/or device companies across 149 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 274 Medicare services$ $2,767 industry payments

Medicare Practice Summary

Medicare Utilization ↗
274
Medicare services
Bottom 19% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
165
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)212$65$180
New patient office visit (45-59 min)25$97$283
New patient office visit (30-44 min)20$81$333
Office visit, established patient (20-29 min)17$37$125
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,767
Total received (2018-2024)
Avg $395/year across 7 years
Bottom 47% in TX for hematology & oncology
46
Companies
149
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,503 (90.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$265 (9.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$833
2023
$221
2022
$266
2021
$265
2020
$483
2019
$476
2018
$223

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$219
Novartis Pharmaceuticals Corporation
$173
Janssen Biotech, Inc.
$171
Amgen Inc.
$160
E.R. Squibb & Sons, L.L.C.
$147
GENZYME CORPORATION
$145
Merck Sharp & Dohme LLC
$125
Pharmacyclics LLC, An AbbVie Company
$125
Eisai Inc.
$93
Dendreon Pharmaceuticals LLC
$89
PFIZER INC.
$86
Astellas Pharma US Inc
$82
Novocure Inc.
$72
SANOFI-AVENTIS U.S. LLC
$72
Daiichi Sankyo Inc.
$69
Merck Sharp & Dohme Corporation
$68
Regeneron Healthcare Solutions, Inc.
$53
Seagen Inc.
$51
Karyopharm Therapeutics Inc.
$51
Genentech USA, Inc.
$47
Celgene Corporation
$47
ARRAY BIOPHARMA INC
$44
Clovis Oncology, Inc.
$44
ABBVIE INC.
$43
Lilly USA, LLC
$41
TerSera Therapeutics LLC
$39
Fresenius Kabi USA, LLC
$36
Incyte Corporation
$31
AbbVie Inc.
$28
Foundation Medicine, Inc.
$28
Medtronic, Inc.
$25
Bayer HealthCare Pharmaceuticals Inc.
$23
Siemens Medical Solutions USA, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Aveo Pharmaceuticals, Inc.
$20
Mirati Therapeutics, Inc.
$19
MorphoSys, US Inc.
$19
Verastem, Inc.
$19
Gilead Sciences, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$16
BeiGene USA, Inc.
$15
Rigel Pharmaceuticals, Inc.
$12
EMD Serono, Inc.
$12
EISAI INC.
$11
GlaxoSmithKline, LLC.
$11
Top 3 companies account for 20.3% of total payments
Associated products mentioned in payments ›
ALIMTA · Alecensa · Aliqopa · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Copiktra · DARZALEX · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · GILOTRIF · GIVLAARI · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Neulasta · Nplate · ONUREG · OPDIVO · OSTEOCOOL RF ABLATION SYSTEM · Optune · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Prolia · REBLOZYL · Rubraca · SARCLISA · SOMATOM go.Top · SPRYCEL · Stimufend · TUKYSA · Tavalisse · Trodelvy · VENCLEXTA · XALKORI · XPOVIO · XTANDI · Xermelo · Xtandi · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,010 per 100 Medicare services performed
Looking for a hematology & oncology in Mount Pleasant?
Compare hematology & oncologys in the Mount Pleasant area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
1
Per 100K population
3.2
County median income
$59,220
Nearest hospital
TITUS REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Singh performed 212 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $2,767 from 46 companies across 149 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other hematology & oncologys in Mount Pleasant?
Dr. Singh's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →